These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 30367334)

  • 1. Comparison of Monitor-Image and Printout-Image Methods in Ki-67 Scoring of Gastroenteropancreatic Neuroendocrine Tumors.
    Dogukan FM; Yilmaz Ozguven B; Dogukan R; Kabukcuoglu F
    Endocr Pathol; 2019 Mar; 30(1):17-23. PubMed ID: 30367334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digital image analysis of Ki67 hotspot detection and index counting in gastroenteropancreatic neuroendocrine neoplasms.
    Saetiew K; Angkathunyakul N; Hunnangkul S; Pongpaibul A
    Ann Diagn Pathol; 2024 Aug; 71():152295. PubMed ID: 38547761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variability of the Ki-67 proliferation index in gastroenteropancreatic neuroendocrine neoplasms - a single-center retrospective study.
    Shi H; Zhang Q; Han C; Zhen D; Lin R
    BMC Endocr Disord; 2018 Jul; 18(1):51. PubMed ID: 30055596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastroenteropancreatic High-Grade Neuroendocrine Neoplasms: Histology and Molecular Analysis, Two Sides of the Same Coin.
    Busico A; Maisonneuve P; Prinzi N; Pusceddu S; Centonze G; Garzone G; Pellegrinelli A; Giacomelli L; Mangogna A; Paolino C; Belfiore A; Kankava K; Perrone F; Tamborini E; Pruneri G; Fazio N; Milione M
    Neuroendocrinology; 2020; 110(7-8):616-629. PubMed ID: 31557757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastroenteropancreatic grade 3 neuroendocrine tumors: a single entity or a heterogeneous group? A retrospective analysis.
    Laffi A; Spada F; Bagnardi V; Frassoni S; Pisa E; Rubino M; Barberis M; Fazio N
    J Endocrinol Invest; 2022 Feb; 45(2):317-325. PubMed ID: 34282554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors for gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): what's better?
    Milione M
    Endocrine; 2018 Jan; 59(1):1-3. PubMed ID: 28417314
    [No Abstract]   [Full Text] [Related]  

  • 7. Ki-67 proliferation index in neuroendocrine tumors: Can augmented reality microscopy with image analysis improve scoring?
    Satturwar SP; Pantanowitz JL; Manko CD; Seigh L; Monaco SE; Pantanowitz L
    Cancer Cytopathol; 2020 Aug; 128(8):535-544. PubMed ID: 32401429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent updates on grading and classification of neuroendocrine tumors.
    Kim JY; Hong SM; Ro JY
    Ann Diagn Pathol; 2017 Aug; 29():11-16. PubMed ID: 28807335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of the Ki-67 proliferation marker as a prognostic factor in gastroenteropancreatic neuroendocrine tumours.
    Foltyn W; Zajęcki W; Marek B; Kajdaniuk D; Siemińska L; Zemczak A; Kos-Kudła B
    Endokrynol Pol; 2012; 63(5):362-6. PubMed ID: 23115069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Three Ki-67 Index Quantification Methods and Clinical Significance in Pancreatic Neuroendocrine Tumors.
    Kroneman TN; Voss JS; Lohse CM; Wu TT; Smyrk TC; Zhang L
    Endocr Pathol; 2015 Sep; 26(3):255-62. PubMed ID: 26072124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy of visual assessments of proliferation indices in gastroenteropancreatic neuroendocrine tumours.
    Young HT; Carr NJ; Green B; Tilley C; Bhargava V; Pearce N
    J Clin Pathol; 2013 Aug; 66(8):700-4. PubMed ID: 23703851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of an Image-based Automated Detection System in Detecting Ki67 Proliferation Index and Correlation with the Traditional Eye-Ball Method in Gastroenteropancreatic Neuroendocrine Tumors.
    Dere Y; Ozkaraca O; Cetin G; Dere O
    J Coll Physicians Surg Pak; 2019 Feb; 29(2):137-140. PubMed ID: 30700352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ki-67 Proliferation Index Assessment in Gastroenteropancreatic Neuroendocrine Tumors by Digital Image Analysis With Stringent Case and Hotspot Level Concordance Requirements.
    Boukhar SA; Gosse MD; Bellizzi AM; Rajan K D A
    Am J Clin Pathol; 2021 Sep; 156(4):607-619. PubMed ID: 33847759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High VEGF serum values are associated with locoregional spread of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
    Cigrovski Berković M; Čačev T; Catela Ivković T; Marout J; Ulamec M; Zjačić-Rotkvić V; Kapitanović S
    Mol Cell Endocrinol; 2016 Apr; 425():61-8. PubMed ID: 26805636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Grade Assignment by Ki-67 Proliferative Index, Mitotic Count, and Phosphohistone H3 Count in Surgically Resected Gastrointestinal and Pancreatic Neuroendocrine Tumors.
    Murphy CE; McCormick KA; Shankaran V; Reddi DM; Swanson PE; Upton MP; Papanicolau-Sengos A; Khor S; Westerhoff M
    Pancreas; 2017; 46(10):1359-1365. PubMed ID: 29040195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ki-67 Labeling Index Variability Between Surgically Resected Primary and Metastatic Hepatic Lesions of Gastroenteropancreatic Neuroendocrine Neoplasms.
    Furukawa T; Ozaka M; Takamatsu M; Takazawa Y; Inamura K; Inoue Y; Mie T; Takeda T; Kanata R; Kasuga A; Matsuyama M; Sasaki T; Takahashi Y; Sasahira N
    Int J Surg Pathol; 2021 Aug; 29(5):475-481. PubMed ID: 33543658
    [No Abstract]   [Full Text] [Related]  

  • 17. Grade Increases in Gastroenteropancreatic Neuroendocrine Tumor Metastases Compared to the Primary Tumor.
    Grillo F; Albertelli M; Brisigotti MP; Borra T; Boschetti M; Fiocca R; Ferone D; Mastracci L
    Neuroendocrinology; 2016; 103(5):452-9. PubMed ID: 26337010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digital Image Analysis of the Proliferation Markers Ki67 and Phosphohistone H3 in Gastroenteropancreatic Neuroendocrine Neoplasms: Accuracy of Grading Compared With Routine Manual Hot Spot Evaluation of the Ki67 Index.
    Lea D; Gudlaugsson EG; Skaland I; Lillesand M; Søreide K; Søreide JA
    Appl Immunohistochem Mol Morphol; 2021 Aug; 29(7):499-505. PubMed ID: 33758143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Objective quantification of the Ki67 proliferative index in neuroendocrine tumors of the gastroenteropancreatic system: a comparison of digital image analysis with manual methods.
    Tang LH; Gonen M; Hedvat C; Modlin IM; Klimstra DS
    Am J Surg Pathol; 2012 Dec; 36(12):1761-70. PubMed ID: 23026928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KI-67 heterogeneity in well differentiated gastro-entero-pancreatic neuroendocrine tumors: when is biopsy reliable for grade assessment?
    Grillo F; Valle L; Ferone D; Albertelli M; Brisigotti MP; Cittadini G; Vanoli A; Fiocca R; Mastracci L
    Endocrine; 2017 Sep; 57(3):494-502. PubMed ID: 28726181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.